These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

417 related items for PubMed ID: 1678378

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Rationale for new oral contraceptive dosing.
    Williams JK.
    Int J Fertil Womens Med; 2004; 49(1):30-5. PubMed ID: 15038507
    [Abstract] [Full Text] [Related]

  • 23. Cycle control and side effects of a new combiphasic oral contraceptive regimen.
    Dieben TO, op ten Berg MT, Coelingh Bennink HJ.
    Arzneimittelforschung; 1994 Jul; 44(7):877-9. PubMed ID: 7945527
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Clinical experience with a triphasic oral contraceptive ('Trinordiol') in young women.
    Gaspard UJ, Deville JL, Dubois M.
    Curr Med Res Opin; 1983 Jul; 8(6):395-404. PubMed ID: 6406157
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Efficacy and safety of a monophasic and a triphasic oral contraceptive containing norgestimate.
    Corson SL.
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1556-61. PubMed ID: 8178906
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Clinical experience in Switzerland with the new monophasic oral contraceptive Minulet (75 mcg gestodene, 30 mcg ethinyl oestradiol).
    Privrel T, Daubenfeld O.
    Br J Clin Pract; 1988 Jul; 42(7):292-8. PubMed ID: 3075505
    [Abstract] [Full Text] [Related]

  • 34. Clinical review of a monophasic oral contraceptive containing desogestrel and ethinyl estradiol.
    Stone S.
    Int J Fertil Menopausal Stud; 1993 Jul; 38 Suppl 3():117-21. PubMed ID: 8260969
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. A comparison study of lipid and androgen metabolism with triphasic oral contraceptive formulations containing norgestimate or levonorgestrel.
    Janaud A, Rouffy J, Upmalis D, Dain MP.
    Acta Obstet Gynecol Scand Suppl; 1992 Jul; 156():33-8. PubMed ID: 1324555
    [Abstract] [Full Text] [Related]

  • 39. Clinical experience of a combined oral contraceptive with very low dose ethinyl estradiol.
    Akerlund M.
    Acta Obstet Gynecol Scand Suppl; 1997 Jul; 164():63-5. PubMed ID: 9225641
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.